As per the research conducted by GME, the Automated Biopsy Guns & Needles Market will grow with a CAGR value of 6.5 percent. High cancer prevalence across the US and Asian countries and increasing preference for pre-cancer diagnostic procedures are the supporting factors for the rising demand for automated biopsy guns. Moreover, factors such as the increasing supportive initiatives by the government and major healthcare organizations for cancer awareness and early diagnosis, and the rising demand for minimally invasive procedures will support the market demand.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Automated Biopsy Guns & Needles Market - Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-automated-biopsy-guns-needles-market-2872
By Product Type (Automatic, and Semi-Automatic), By Gauge Size (14 Gauge Biopsy Needle, 16 Gauge Biopsy Needle, and 18 Gauge Biopsy Needle), By Usage (Disposable and Reusable), By Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy, Kidney Biopsy, Colorectal Biopsy, Bone Biopsy, and Other Application), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
· The most common type of biopsy conducted across all the markets is the kidney biopsy and hence it will be the largest and dominant segment
· The disposable automated biopsy guns will be the dominant segment in the market from the forecast period of 2021 to 2026
· Automatic Biopsy guns and needles are devices that use a disposable needle to extract high quality and specific histological specimens from the patient
· Argon Medical Devices, Biopsybell, Histo, STERYLAB, Vigeo, Merit Medical System, Adria Medical, UROMED Kurt Drews KG, Mermaid Medical, Medi-Tech Devices, weLLgo Medical Products GmbH, Zamar Care, Seedos Ltd, Delta Surgical, Advin Health Care, Blue Neem Medical Devices Pvt Ltd, Möller Medical GmbH, Geotek Medical, Varaylaborix, and Advanced Life-sciences PVT. LTD. among others are the players in the automated biopsy guns & needles market
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-automated-biopsy-guns-needles-market-2872
Product Type Outlook (Revenue, USD Billion, 2021-2026)
· Automatic
· Semi-Automatic
Gauge Size Outlook (Revenue, USD Billion, 2021-2026)
· 14 Gauge Biopsy Needle
· 16 Gauge Biopsy Needle
· 18 Gauge Biopsy Needle
Usage Outlook (Revenue, USD Billion, 2021-2026)
· Disposable
· Reusable
Application Outlook (Revenue, USD Billion, 2021-2026)
· Breast Biopsy
· Lung Biopsy
· Prostate Biopsy
· Kidney Biopsy
· Colorectal Biopsy
· Bone Biopsy
· Other Application
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Rest of APAC
Central & South America
Brazil
Argentina
Rest of CSA
Middle East & Africa
Saudi Arabia
UAE
Rest of MEA
Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
Industries
Reports
Services
Newsroom
Next-Gen Expertise About Us
Contact Us
Blog
Category Healthcare
Format
Request Free
Sample
Buy Now
Automated Biopsy Guns & Needles Market Insights
Automatic biopsy guns and needles are devices that use a disposable needle to extract high-quality
and specific histological specimens from the patient. It is a methodology to extract cells and tissues
from the patient’s body by embedding a needle in the tumor site. The extricated tissue is then utilized
for lab testing in order to discover any irregularity and abnormalities. The major application of biopsy
is the detection or presence of mass or a lump, infection, and any type of inflammation. A biopsy is
most commonly used for cancer tumor detection across the globe. The market commonly has fine-
needle aspiration and core needle biopsy which is regularly used for cancer diagnostics. Tissues or
samples such as bones, blood samples, muscles, and,organ samples of lung and liver are mainly
extracted. However, the market for needle biopsy is moving towards using automatic and semi-
automatic biopsy guns. Automatic biopsy needles or guns are spring-loaded for quick and accurate
penetration and extraction of tissue samples. The automatic type allows the user to get a précised
controlover the extraction and also renders high-quality sampling capability the users need while
handling and working with hard, calcified,and fibrous tumors/ lesions. Hence, this single-hand
operating device is taking over the market and will grow with a higher CAGR rate from 2021-2026. The
major end-users for automatic biopsy needles are cancer hospitals, clinics, and research centers that
perform cancer profiling for pre and post-diagnostic purposes.
Rising cancer prevalence across the world and increasing preference for pre-cancer diagnosis are
supporting the rising demand for biopsy guns. Moreover, factors such as the increasing supportive
initiatives by the government and major healthcare organizations for cancer awareness and early
diagnosis, and the